Albendazole microbiology: Difference between revisions
Jump to navigation
Jump to search
Gerald Chi (talk | contribs) (Created page with "__NOTOC__ {{Albendazole}} {{CMG}} <ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = ALBENZA (ALBENDAZOLE) TABLET, FILM COATED [AMEDRA PHARMACEUT...") |
Gerald Chi (talk | contribs) mNo edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}} | {{CMG}} | ||
==Microbiology== | |||
The principal mode of action for albendazole is by its inhibitory effect on tubulin polymerization which results in the loss of cytoplasmic microtubules. | |||
In the specified treatment indications albendazole appears to be active against the larval forms of the following organisms:<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = ALBENZA (ALBENDAZOLE) TABLET, FILM COATED [AMEDRA PHARMACEUTICALS LLC] | url =http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e8941166-b77d-45aa-a6e8-04f1c0afd845 | publisher = | date = | accessdate = }}</ref> | |||
* [[Echinococcus granulosus]] | |||
* [[Taenia solium]] | |||
==References== | ==References== | ||
Latest revision as of 23:55, 6 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Microbiology
The principal mode of action for albendazole is by its inhibitory effect on tubulin polymerization which results in the loss of cytoplasmic microtubules.
In the specified treatment indications albendazole appears to be active against the larval forms of the following organisms:[1]
References
Adapted from the FDA Package Insert.